Podcasts

Episode 17 | The need for a National Clinical Quality Registry in Lung Cancer

In this episode, Respiratory Physicians Prof Emily Stone , Prof Rob Stirling and Prof Fraser Brims discuss the need for funding for a national quality registry for lung cancer patients.

The need for a National Clinical Quality Registry in Lung Cancer

Episode Summary

The first TOGA Podcast for 2022 is about the need for a national clinical quality registry in lung cancer. Prof Emily Stone is joined by Prof Rob Stirling and also Prof Fraser Brims. In this episode, Respiratory Physicians discuss the need for funding for a national quality registry for lung cancer patients. In addition, they explore the vision of what a clinical quality process should look like for lung cancer regarding mortality reduction strategies and the real-world impact of new treatment/management strategies for lung cancer patients.

The high burden of disease and poor outcomes in lung cancer necessitate provision of optimal and timely care to ensure the best possible outcomes for people with lung cancer. A national clinical quality registry will reduce unwarranted variation in care by benchmarking performance and evaluate strategies designed to improve care, such as the expected lung cancer screening program. Registries are not just about collecting data. Examples of varied care in lung cancer and a vision of what a clinical quality process should look like for lung cancer is explored in this podcast, together with an urgent call to action to demand funding for a national Clinical Quality Registry for lung cancer.

Show Hosts

This episode’s host are:

  • Prof Emily Stone, Deputy Chair, TOGA; Respiratory Physician, Senior Staff Specialist and Head of Thoracic Medicine, Department of Thoracic Medicine and Lung Transplantation, St Vincent’s Hospital Sydney; conjoint Senior Lecturer, University of New South Wales; Chair, St Vincent’s Hospital Lung Cancer Multidisciplinary team
  • A/Prof Rob Stirling, Respiratory Physician, the Alfred and Monash University; lead, Victorian Lung Cancer Registry (VLCR)
  • Prof Fraser Brims, Consultant Respiratory Physician, Sir Charles Gardiner Hospital; Director of Early Years Clinical Skills, Curtin University Medical School and Institute of Medical Health

Play Episode 17 | The need for a National Clinical Quality Registry in Lung Cancer

More Podcasts

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining